Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Supporters

This activity is supported by educational grants from Celgene Corporation, Genentech, Lilly USA, LLC, and Novartis Pharmaceuticals Corporation.

8th Annual New York Lung Cancer Symposium®

8th Annual New York Lung Cancer Symposium®

November 9, 2013
Crowne Plaza® Times Square - Manhattan
New York, NY


The 8th Annual New York Lung Cancer Symposium® is a one-day meeting which will serve as an update on advances in the field and will focus on the future of lung cancer treatment including: molecular subsets, targeted agents in development, treatment options in early stage, screening, the ongoing guideline debate, and a look forward from the experts.

Participants will learn from engaging presentations delivered by thought leaders and by reviewing and discussing realistic and complex scenarios, sharing clinical experiences, understanding well-established and emerging unmet therapeutic opportunities, solving clinical problems, and clarifying best practices. Participants will actively respond to and interact with the faculty through informal questions and open discussion, and as a result of this approach will leave with a higher level of understanding than they would otherwise achieve.

Click here to download brochure

Target Audience

This educational activity is directed toward medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists involved in the treatment and management of patients with lung cancer.  Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer may also participate.

Disclosure Policy and Conflict of Interest (COI)

As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months that create a COI.

Additionally, PER® is required by ACCME to resolve all COI. We have identified and resolved all COI prior to the start of this activity by using a multi-step process.

Faculty and Staff Disclosure

The following individuals have no relevant financial relationships with commercial interests to disclose:

Jorge E. Gomez, MD and Natasha B Leighl, BSc, MD, MSc.

The staff of Physicians' Education Resource®, LLC: Leigh Anne Bongiovanni; Ann C. Lichti, CCMEP; Dru Dace, PhD; and Megan O'Connell.

The following individuals have relevant financial relationships with commercial interests to disclose:

Abraham Chachoua, MD —Speaker’s Bureau: Eli Lilly; Richard J. Gralla, MD —Consultant: Eisai; Eli Lilly; Helsinn; Merck; Other Support: Lectures sponsored by Eisai; Helsinn; Merck; Balazs Halmos, MD —Grant/Research Support: Eli Lilly; Roche; Astex; Daiichi; Boehringer-Ingelheim; Bristol-Myers-Squibb; Merck; Astra-Zeneca; Oncothyreon; Astellas; Pfizer; Mirati; Harry D. Harper, MD – Speaker’s Bureau: Eli Lilly; Mark G. Kris, MD —Grant/Research Support: Pfizer Inc.; POMA; Boehringer-Ingelheim; Consultant: Novartis Pharmaceuticals Corporation; Pfizer Inc.; Genentech/Roche; Boehringer-Ingelheim; Benjamin P. Levy, MD —Consultant: Genentech; Pfizer Inc.; Speaker’s Bureau: Eli Lilly; Genentech; Pfizer Inc.; Roman Perez-Soler, MD —Speaker’s Bureau: Eli Lilly; Genentech; Bilal Piperdi, MD —Consultant: Amgen; Speaker’s Bureau: Genentech/Roche; Celgene Corporation; Merck; Pfizer, Inc.; Harry Raftopoulos, MD — Grant/Research Support: Novartis Pharmaceuticals Corporation; Roche; Pfizer Inc.; Eisai; Consultant: Merck; Gregory J. Riely,  MD,  PhD —Grant/Research Support: Chugai/Roche; Infinity; Pfizer; Novartis; Merk; Millennium; Consultant: Ariad; Naiyer A. Rizvi, MD —Grant/Research Support: Bristol-Myers-Squibb; Roche/Genentech; Medimmune; Merck; Consultant: Bristol-Myers-Squibb; Roche/Genentech; Medimmune; Charles M. Rudin, MD, PhD —Consultant: Celgene Corporation; Bryan J. Schneider, MD —Grant/Research Support: Celgene Corporation; Eli Lilly; Boehringer-Ingelheim; Consultant: Genentech; Speaker’s Bureau: Genentech; Pfizer Inc.; Alice T. Shaw, MD, PhD —Consultant: Pfizer Inc.; Novartis Pharmaceuticals Corporation; Ariad; Genentech; Steven E Vogl, MD —Stock/Shareholder: Amgen; Bristol-Myers-Squibb; Other Support: Advisory Board Celgene Corporation

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I acknowledge that Company may share my personal information for the purpose of contact tracing if the need arises, and I hereby consent to the release of my personal information for such purpose. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Calendar of Events
Filter By